2026-01-22 - Analysis Report
# Financial Report for Lam Research (LRCX)

## 1. Return Rate Analysis
- **Cumulative Return of Lam Research (LRCX):** 322.13%
- **Cumulative Return of S&P 500 (VOO):** 91.55%
- **Divergence:** 221.80%

**Company Overview:** Lam Research is a global supplier of wafer fabrication equipment and services to the semiconductor industry.

### Analysis:
- LRCX significantly outperforms the S&P 500, with a divergence of 221.80%, indicating strong relative performance.

### Alpha, Beta Analysis:
| Year       | CAGR  | MDD   | Alpha | Beta   | Cap(B) |
|------------|-------|-------|-------|--------|--------|
| 2016-2018  | 0.0%  | 34.0% | -5.0% | 1.6    | 17.2   |
| 2017-2019  | 38.0% | 34.0% | 20.0% | 1.7    | 36.9   |
| 2018-2020  | 57.0% | 34.0% | 36.0% | 1.5    | 59.5   |
| 2019-2021  | 105.0%| 24.4% | 62.0% | 1.6    | 90.7   |
| 2020-2022  | -10.0%| 49.0% | -8.0% | 1.6    | 53.0   |
| 2021-2023  | -13.0%| 49.0% | -14.0%| 1.8    | 98.8   |
| 2022-2024  | -46.0%| 42.4% | -66.0%| 1.9    | 91.1   |
| 2023-2025  | 149.0%| 43.7% | 87.0% | 2.0    | 215.9  |

- **Analysis:** The 2019-2021 period shows remarkable growth with a CAGR of 105.0% and significant alpha. However, recent periods show negative performance, highlighting volatility.

## 2. Recent Stock Price Fluctuations
- **Current Close Price:** $228.39
- **5-day SMA:** $220.00
- **20-day SMA:** $198.53
- **60-day SMA:** $171.26

### Analysis:
- The recent close indicates an upward trend compared to the moving averages, particularly the 5-day and 20-day SMAs, suggesting positive momentum.

## 3. Indicators Analysis
- **Market Risk Indicator (MRI):** 0.80 (Medium Investment)
- **RSI:** 78.40 (Overbought)
- **PPO:** 0.71
- **Hybrid Signal:** Buy (Cash 0%)
- **Expected Return:** 11.10%

### Analysis:
- The high RSI suggests LRCX is overbought, and the MRI indicates medium risk, suggesting cautious optimism. The expected return is promising for long-term investment.

## 4. Recent News & Significant Events
- **[2026-01-21]** Lam Research: Winning As Chips Go Vertical (link)
- **[2026-01-02]** LRCX Outperformed in 2025, but Valuation and Options Activity Flag 2026 Risks (link)
- **[2026-01-15]** What Makes Lam Research (LRCX) a Strong Momentum Stock: Buy Now? (link)
- **[2026-01-21]** Assessing Lam Research (LRCX) Valuation As Analyst Optimism Meets Earnings And Tariff Uncertainty (link)
- **[2026-01-21]** LRCX: Deutsche Bank Raises Price Target to $260, Maintains Buy Rating (link)
- **[2026-01-15]** Lam Research Soars 165% in a Year: Is LRCX Stock Still a Buy? (link)

### Analysis:
- Recent news indicates strong analyst interest and upward price targets, although concerns about valuation and future risks exist.

## 4-2. Analyst Opinions
```text
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.72 (~Buy)
- Opinions: 31
- Target Price (avg/high/low): 206.13 / 265.00 / 115.00
```

## 5. Recent Earnings Analysis
| Date       | EPS  | Revenue  |
|------------|------|----------|
| 2025-10-24 | 1.24 | 5.32 B$  |
| 2025-04-25 | 1.04 | 4.72 B$  |
| 2025-01-31 | 0.93 | 4.38 B$  |
| 2024-10-28 | 0.86 | 4.17 B$  |
| 2025-10-24 | 0.86 | 4.17 B$  |

### Analysis:
- EPS and revenue have shown an upward trend, indicating strong financial health and profitability for Lam Research.

## 6. Financial Information
### Revenue and Profitability:
| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $5.32B  | 50.43%        |
| 2025-06-30   | $5.17B  | 50.08%        |
| 2025-03-31   | $4.72B  | 49.02%        |
| 2024-12-31   | $4.38B  | 47.37%        |
| 2024-09-30   | $4.17B  | 48.05%        |

### Capital and Profitability:
| Quarter      | Equity  | ROE   |
|--------------|---------|-------|
| 2025-09-30   | $10.19B | 15.39%|
| 2025-06-30   | $9.86B  | 17.44%|
| 2025-03-31   | $9.51B  | 13.99%|
| 2024-12-31   | $8.81B  | 13.52%|
| 2024-09-30   | $8.47B  | 13.18%|

### Analysis:
- Revenue growth is accompanied by stable profit margins, while ROE shows slight fluctuations but remains relatively strong.

## 7. Comprehensive Analysis
- Lam Research exhibits strong cumulative returns compared to the S&P 500. Recent stock price trends and positive analyst opinions bolster its outlook. Despite medium risk indicated by the MRI and a high RSI, the company's earnings and profitability metrics reflect robust financial health. Recent news highlights both opportunities and potential valuation risks.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.